Publications



Publications

Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis

Auteurs : “18. Duvignaud A, Stoney RJ, Angelo KM, Chen LH, Cattaneo P, Motta L, Gobbi FG, Bottieau E, Bourque DL, Popescu CP, Glans H, Asgeirsson H, Oliveira-Souto I, Vaughan SD, Amatya B, Norman FF, Waggoner J, Díaz-Menéndez M, Beadsworth M, Odolini S, Camprubí-Ferrer D, Epelboin L, Connor BA, Eperon G, Schwartz E, Libman M, Malvy D, Hamer DH, Huits R, GeoSentinel Network”

2024

Journal

J Travel Med 31(7):taae089

Voir...

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)

Auteurs : “19. Egger M, Sauermann M, Loosli T, Hossmann S, Riedo S, Beerenwinkel N, Jaquet A, Minga A, Ross JL, Giandhari J, Kouyos R, Lessells R”

2024

Journal

medRxiv :2024.05.23.24307850

Voir...

Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial

Auteurs : “20. Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni T, Ouédraogo A-S, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F, FIT-2 study group”

2024

Journal

Lancet HIV 11(6):e380–e388

Voir...

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries

Auteurs : “1. Aghokeng AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, D’Aquin Toni T, Maiga AI, Dramane K, Eymard-Duvernay S, Chaix M-L, Calvez V, Descamps D”

2024

Journal

Voir...